Aldeyra The (ALDX)

Aldeyra The (ALDX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $42.2M; returns 1 day +0.7%, 1 week -7.2%, 1 year -87.5%.

Aldeyra Therapeutics, Inc. is a biotechnology company dedicated to the discovery and development of innovative therapies for immune-mediated diseases. Its core scientific approach involves modulating protein systems, specifically reactive aldehyde species (RASP), to address multiple disease pathways simultaneously while aiming to minimize toxicity.

Groups ALDX belongs to

• Biotechnology
• Biopharmaceutical
• Healthcare
• Ophthalmology
• Clinical Stage Biotech
• Clinical Stage
• Autoimmune Diseases
• Rare Diseases
• Life Sciences
• Drug Discovery

ALDX financial model: income statement, cash flow and balance sheet